Preclinical evaluation of a COVID-19 vaccine candidate based on a recombinant RBD fusion heterodimer of SARS-CoV-2
Barreiro, Antonio, Prenafeta, Antoni, Bech-Sabat, Gregori, Roca, Mercè, Perozo Mur, Eva, March, Ricard, González-González, Luis, Madrenas, Laia, Corominas, Júlia, Fernández, Alex, Moros, Alexandra, Cañete, Manuel, Molas, Mercè, Pentinat-Pelegrin, Thais, Panosa, Clara, Moreno, Alberto, Puigvert Molas, Ester, Pol Vilarrassa, Eva, Palmada, Jordi, Garriga, Carme, Prat Cabañas, Teresa, Iglesias-Fernández, Javier, Vergara-Alert, Júlia, Lorca-Oró, Cristina, Roca, Núria, Fernández-Bastit, Leira, Rodon, Jordi, Pérez, Mònica, Segalés, Joaquim, Pradenas, Edwards, Marfil, Silvia, Trinité, Benjamin, Ortiz, Raquel, Clotet, Bonaventura, Blanco, Julià, Díaz Pedroza, Jorge, Ampudia Carrasco, Rosa, Rosales Salgado, Yaiza, Loubat-Casanovas, Jordina, Capdevila Larripa, Sara, Prado, Julia Garcia, Barretina, Jordi, Sisteré-Oró, Marta, Cebollada Rica, Paula, Meyerhans, Andreas, Ferrer, Laura
Published in iScience (17.03.2023)
Published in iScience (17.03.2023)
Get full text
Journal Article